Peter-Paul Zwetsloot (@ppmzwetsloot) 's Twitter Profile
Peter-Paul Zwetsloot

@ppmzwetsloot

MD, PhD, Epidemiologist. cardiologist and translational researcher @ErasmusMC. coordinator Dutch Cardiomyopathy Database

ID: 972754208

calendar_today26-11-2012 21:34:29

145 Tweet

109 Followers

231 Following

TrialsChangLives (@goodluckjbers14) 's Twitter Profile Photo

#CochraneDaily 🎧 PODCAST🎧In 4 min learn from Peter-Paul Zwetsloot of University Medical Centre Utrecht about 3rd update of The Cochrane Library Review of stem cells for myocardial infarction: high certainty evidence of lack of important benefits UMC Utrecht cochrane.org/podcasts/10.10…

Peter-Paul Zwetsloot (@ppmzwetsloot) 's Twitter Profile Photo

Extra attention for our recent analyses on clinical trials for bone marrow cell therapy in acute MI! An important update of the Cochrane Review. Listen to the podcast or read the paper through the link 👇 Many thanks for the spotlight 🙏

Jozine ter Maaten (@jozinetm) 's Twitter Profile Photo

After a successful first #HFA journal club 📖 make sure you don’t miss our 2️⃣nd edition! #HFAYoung ❓Get to know more about the rapidly evolving treatment options for #HCM and discuss the ins and out of SEQOUIA-HCM 🫀 📆 October 23rd ⏰ 18:00 CEST Register now ⬇️

After a successful first #HFA journal club 📖 make sure you don’t miss our 2️⃣nd edition! #HFAYoung
❓Get to know more about the rapidly evolving treatment options for #HCM and discuss the ins and out of SEQOUIA-HCM 🫀
📆 October 23rd
⏰ 18:00 CEST
Register now ⬇️
Young@Heart (@youngatheartnl) 's Twitter Profile Photo

📢Fall event open for registration! Do you ever wonder about the next step after your PhD? Join us on Nov 22nd in Utrecht to hear from people with different career paths, get inspired by Prof. Gommers, and follow a workshop to (re)shape your future. Registration via QR below 1/2

📢Fall event open for registration!
Do you ever wonder about the next step after your PhD? 
Join us on Nov 22nd in Utrecht to hear from people with different career paths, get inspired by Prof. Gommers, and follow a workshop to (re)shape your future.
Registration via QR below
1/2
Niccolo' Maurizi (@mauriziniccolo) 's Twitter Profile Photo

🎯SRT in HCM: long-term evolution & predictors of outcome ? 🥇1832 pts, 10 ys after the SRT: 83% alive.⬆️ age at intervention ⬇️ survival. 🥈13% de novo HF (⬆️age & females) Low SCD over f-up (0.7%) 🥉Peri-procedural outcome in ⬆️ clinical vol HCM centers meets AHA/ACC metrics.

🎯SRT in HCM: long-term evolution & predictors of outcome ?
🥇1832 pts, 10 ys after the SRT: 83% alive.⬆️ age at intervention ⬇️ survival. 
🥈13% de novo HF (⬆️age & females) Low SCD over f-up (0.7%)
🥉Peri-procedural outcome in ⬆️ clinical vol HCM centers meets AHA/ACC metrics.
Sukriti Banthiya, MD (@sukritibanthiya) 's Twitter Profile Photo

Steve Ommen, MD 7/ Clinical Pearl 🦪 - Obstruction begets diastolic dysfunction” 💕 ⬆️ LV filling pressures -> Coronary perfusion -> ischemia🩸-> diastolic dysfunction -> ⬆️ LA pressures -> LV filling pressures

<a href="/SteveOmmen/">Steve Ommen, MD</a> 7/ Clinical Pearl 🦪 - Obstruction begets diastolic dysfunction” 

💕 ⬆️ LV filling pressures -&gt; Coronary perfusion -&gt; ischemia🩸-&gt; diastolic dysfunction -&gt; ⬆️ LA pressures -&gt; LV filling pressures
Jozine ter Maaten (@jozinetm) 's Twitter Profile Photo

Pearls from the keynote on #nextsteps by diederikgommers at the @YounAtHeartNL fall event 🍂 🍁 be authentic 🍁 be empathetic 🍁 communicate a positive message 🍁 add value from your expertise

Pearls from the keynote on #nextsteps by <a href="/diederikgommer1/">diederikgommers</a> at the @YounAtHeartNL fall event 🍂
🍁 be authentic
🍁 be empathetic 
🍁 communicate a positive message
🍁 add value from your expertise
Jozine ter Maaten (@jozinetm) 's Twitter Profile Photo

⏰ now is the time to submit your #science for #heartfailure2025 Grab your 💻 and a ☕️ and submit your #abstract before 📆 January 10th 🙋‍♀️ member of the #HFAYoung? Participate in the Young Investigator Award 🏆 and apply for a travel grant 🧳 ➡️ escardio.org/Congresses-Eve…

⏰ now is the time to submit your #science for #heartfailure2025
Grab your 💻 and a ☕️ and submit your #abstract before 📆 January 10th
🙋‍♀️ member of the #HFAYoung? Participate in the Young Investigator Award 🏆 and apply for a travel grant 🧳
➡️ escardio.org/Congresses-Eve…
CVCT - CardioVascular Clinical Trialists (@cvctforum) 's Twitter Profile Photo

#CVCT2024 : Join us to discuss Prevalence and association of hypertriglyceridemia and obesity  associated cardiovascular risk in Middle East with Samir Naim Assaad, Professor of Medicine & Endocrinology, Alexandria, EGYPT. Cardiovascular (CV) events are getting prevalent all over

#CVCT2024 : Join us to discuss Prevalence and association of hypertriglyceridemia and obesity  associated cardiovascular risk in Middle East with Samir Naim Assaad, Professor of Medicine &amp; Endocrinology, Alexandria, EGYPT. Cardiovascular (CV) events are getting prevalent all over
CVCT - CardioVascular Clinical Trialists (@cvctforum) 's Twitter Profile Photo

#CVCT2024: Day 3 is on ! Running now: GLOBAL REGULATORY SUMMIT, TRIGLYCERIDE RICH LIPOPROTEINS TRIALS, ANTI-OBESITY MEDICINES AND CV OUTCOME TRIALS – RESULTS TO DATE AND IMPLICATIONS, iCVCT session on HOW TO EVOLVE THE DESIGN OF VALVE TRIALS !

#CVCT2024: Day 3 is on ! Running now: GLOBAL REGULATORY SUMMIT, TRIGLYCERIDE RICH LIPOPROTEINS TRIALS, ANTI-OBESITY MEDICINES AND CV OUTCOME TRIALS – RESULTS TO DATE AND IMPLICATIONS, iCVCT session on HOW TO EVOLVE THE DESIGN OF VALVE TRIALS !
European Society of Cardiology (@escardio) 's Twitter Profile Photo

SEQUOIA­HCM: Effect of aficamten treatment on patients with hypertrophic obstructive cardiomyopathy by geographical region discussed by Caroline Coats & Brenda Moura Hosted by Peter-Paul Zwetsloot Watch their #HFASnacks 🤗 #HFA_ESC #HeartFailure2025 HFAPresident

Eric Topol (@erictopol) 's Twitter Profile Photo

The Peptide Craze I review what we know about 15 different injectable peptides being used without FDA approval or off-label, and NAD+ In the new Ground Truths; free, open-access

The Peptide Craze
I review what we know about 15 different injectable peptides being used without FDA approval or off-label, and NAD+
In the new Ground Truths; free, open-access